NeoNavia AB
NeoNavia® is a precision biopsy platform for ultrasound-guided breast and axillary lymph node procedures. Its patented Pulse Technology uses pneumatic, high-velocity needle insertion with short, multi-pulse strokes to enable stepwise, controlled tissue penetration, minimizing deformation and improving diagnostic accuracy. The system includes a base unit, hand-held driver, and three needle options, including an open-tip design for optimized tissue yield.
- Medical Devices
- Healthcare Technology
- Hardware
Funding
Raised to date
SEK 14MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Est. $1.3Macross 1 round
SEK 14M · Undisclosed
Announced Feb 2023
Disclosed cumulative: $1.3M
Founders
Founder details are not available yet.
Product
Problem
Conventional breast and axillary lymph node biopsies often face challenges with precise needle placement, especially in technically demanding ultrasound-guided procedures. This can lead to reduced diagnostic accuracy, the need for repeat procedures, and difficulty obtaining sufficient tissue samples for reliable pathological assessment.
Solution
NeoNavia® provides a new biopsy platform designed to enhance precision and control during ultrasound-guided breast and axillary lymph node biopsies. The system's core innovation is its patented Pulse Technology, a pneumatic needle insertion mechanism that generates high needle acceleration and velocity. This technology, combined with a short stroke length in the order of millimeters and the ability to deliver multiple consecutive pulses, allows physicians to advance the needle through tissue in a controlled, stepwise manner. This approach minimizes tissue deformation and displacement, stabilizes the target lesion, and maintains control throughout the procedure, regardless of tissue properties.
Target Audience
Primary users are radiologists, surgeons, and other clinicians who perform ultrasound-guided breast and axillary lymph node biopsies in hospital and clinical settings.
Features
- Patented Pulse Technology for high-velocity, pneumatic needle insertion with short, multi-pulse strokes
- Stepwise and controlled needle deployment that minimizes tissue deformation and target lesion displacement
- Intuitive 'Click-and-Go' system with a base unit, hand-held driver, and three distinct biopsy needle options
- Needle options include an open-tip design (CorePulse) for optimized tissue yield, with availability varying by region
- Designed to support a wide range of clinical scenarios and demanding diagnostic procedures, including monitoring neoadjuvant treatment response in axillary lymph node biopsies